This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Analyst Reports for Oracle, Micron Technology & Medtronic
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Oracle Corporation (ORCL), Micron Technology, Inc. (MU) and Medtronic plc (MDT), as well as a micro-cap stock The Cato Corporation (CATO).
PRA Group's Shares Up 17.8% Since Q3 Earnings Beat Estimates
by Zacks Equity Research
PRAA's third-quarter results benefit from strong cash collection and portfolio income growth. Higher expenses partially offset the positives.
MarketAxess Q3 Earnings Beat on Strong Credit Trading Volumes
by Zacks Equity Research
MKTX's third-quarter results benefit from higher commissions, driven by improved trading volumes. Higher expenses partially offset the results.
Erie Indemnity Q3 Earnings Top on Higher Management Fee Revenues
by Zacks Equity Research
ERIE's Q3 results reflect higher management fees and increased net investment income, offset by higher expenses.
WTW Q3 Earnings Top on Higher Revenues, Transformation Program
by Zacks Equity Research
Willis Tower's third-quarter results reflect benefits from strong revenue contributions from the Health, Wealth & Career and Risk & Broking segments,
Brown & Brown Q3 Earnings Top Estimates on Higher Revenues
by Zacks Equity Research
BRO's Q3 results reflect improved organic revenues, driven by higher commission and fees and investment income, expanded EBITDAC margin and increased net investment income, offset by higher expenses.
AON Q3 Earnings Beat Estimates on Commercial Risk Solutions Strength
by Zacks Equity Research
AON expects interest expenses to be around $210 million in the fourth quarter of 2024.
Arthur J. Gallagher Q3 Earnings Match Estimates, Revenues Rise Y/Y
by Zacks Equity Research
AJG's third-quarter results reflect higher revenues and margin expansion across the Brokerage and Risk Management segments, partially offset by higher expenses.
Arthur J. Gallagher (AJG) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
While the top- and bottom-line numbers for Arthur J. Gallagher (AJG) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Arthur J. Gallagher (AJG) Matches Q3 Earnings Estimates
by Zacks Equity Research
Arthur J. Gallagher (AJG) delivered earnings and revenue surprises of 0% and 0.15%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Arthur J. Gallagher & Co. (AJG) Stock?
by Zacks Equity Research
Investors need to pay close attention to Arthur J. Gallagher & Co. (AJG) stock based on the movements in the options market lately.
Why Arthur J. Gallagher (AJG) Could Beat Earnings Estimates Again
by Zacks Equity Research
Arthur J. Gallagher (AJG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
4 Insurance Stocks' Q3 Earnings Coming Up: What to Expect
by Sushmita Sarker
Here, we take a look at four insurance stocks, AJG, HIG, CINF and KNSL, which are set to report third-quarter earnings on Oct. 24.
Here's What to Expect From Arthur J. Gallagher's Q3 Earnings
by Zacks Equity Research
AJG's third-quarter results are likely to reflect new business, solid retention and higher renewal premiums across its business lines as well as acquisitions.
To Buy or Not to Buy AON Before Q3 Earnings? That's the Question
by Zacks Equity Research
AON's third-quarter earnings are likely to have benefited from better performance in its Commercial Risk Solutions and Health Solutions segments.
Countdown to Arthur J. Gallagher (AJG) Q3 Earnings: Wall Street Forecasts for Key Metrics
by Zacks Equity Research
Evaluate the expected performance of Arthur J. Gallagher (AJG) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Aon (AON) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Aon (AON) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan Q3 Earnings Beat on Solid Marsh Unit Performance
by Zacks Equity Research
MMC's strong United States/Canada operations are contributing to its positive results.
Arthur J. Gallagher (AJG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Arthur J. Gallagher (AJG) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan Pre-Q3 Earnings: Is it Time to Bet Big or Sit Tight?
by Zacks Equity Research
MMC's third-quarter earnings are likely to have benefited from better performance from its Risk and Insurance Services and Consulting segments.
The Zacks Analyst Blog Highlights Bristol-Myers Squibb, Arthur J. Gallagher, TC Energy and Bridger Aerospace
by Zacks Equity Research
Bristol-Myers Squibb, Arthur J. Gallagher, TC Energy and Bridger Aerospace are part of the Zacks top Analyst Blog.
Top Research Reports for Bristol-Myers, Arthur J. Gallagher & TC Energy
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including Bristol-Myers Squibb Company (BMY), Arthur J. Gallagher & Co. (AJG) and TC Energy Corporation (TRP), as well a micro-cap stock Bridger Aerospace Group Holdings, Inc. (BAER).
Improving Commissions and Fees Aid AJG, High Expenses Ail
by Zacks Equity Research
Arthur J. Gallagher is poised to grow from the solid performance of its Brokerage and Risk Management segments, strategic buyouts and effective capital deployment.
Brown & Brown Strengthens Personal Line With Canopy Buyout
by Zacks Equity Research
BRO's buyout of Canopy not only expands the acquirer's personal line business but also expands its small business commercial offerings.
Zacks Industry Outlook Marsh & McLennan, Arthur J. Gallagher, Brown & Brown and Willis Towers Watson Public
by Zacks Equity Research
Marsh & McLennan, Arthur J. Gallagher, Brown & Brown and Willis Towers Watson Public have been highlighted in this Industry Outlook article.